The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCELERON PHARMA INC | COM | 00434H108 | 6,902 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
ACHILLES THERAPEUTICS PLC | SPONSORED ADS | 00449L102 | 783 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 4,829 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
ACUTUS MED INC | COM | 005111109 | 1,358 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 2,266 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 4,238 | 25,000 | SH | Call | SOLE | 25,000 | 0 | 0 | |
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 632 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
ARK ETF TR | GENOMIC REV ETF | 00214Q302 | 20,813 | 225,000 | SH | Put | SOLE | 225,000 | 0 | 0 | |
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 7,504 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 2,631 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 1,687 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
BCTG ACQUISITION CORP | COM | 05492W103 | 1,138 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 933 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 33,528 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
BUTTERFLY NETWORK INC | COM CL A | 124155102 | 1,448 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 1,672 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 1,487 | 66,957 | SH | SOLE | 66,957 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 5,124 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | *W EXP 06/09/2020 | 15678U102 | 1,043 | 72,466 | SH | SOLE | 72,466 | 0 | 0 | ||
CHARDAN HEALTHCR ACQSTN 2 CO | UNIT 99/99/9999 | 15957T206 | 819 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
CHINOOK THERAPEUTICS INC | COM | 16961L106 | 2,824 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 1,159 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
CUREVAC N V | COM | N2451R105 | 11,022 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | |
CURIS INC | COM NEW | 231269200 | 5,246 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
CVRX INC | COM | 126638105 | 210 | 7,500 | SH | SOLE | 7,500 | 0 | 0 | ||
CYCLACEL PHARMACEUTICALS INC | COM | 23254L603 | 2,250 | 380,000 | SH | SOLE | 380,000 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 1,385 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 475 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 2,000 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | ||
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 1,747 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 1,387 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 700 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
GOSSAMER BIO INC | NOTE 5.000% 6/0 | 38341PAA0 | 1,605 | 2,000,000 | PRN | SOLE | 2,000,000 | 0 | 0 | ||
HARPOON THERAPEUTICS INC | COM | 41358P106 | 694 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 3,060 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 2,341 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
IMMATICS N.V | *W EXP 07/01/2020 | N44445117 | 654 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 317 | 30,000 | SH | Call | SOLE | 30,000 | 0 | 0 | |
INARI MED INC | COM | 45332Y109 | 7,929 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 1,619 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | COM | 462222100 | 2,992 | 75,000 | SH | Call | SOLE | 75,000 | 0 | 0 | |
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 2,602 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 641 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 1,198 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 8,861 | 425,000 | SH | SOLE | 425,000 | 0 | 0 | ||
LIFESCI ACQUISITION II CORP | COM | 53229E103 | 1,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
MACROGENICS INC | COM | 556099109 | 2,149 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | CL A SHS | G5960S108 | 2,895 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
MEDICUS SCIENCES ACQUISITION | *W EXP 02/12/2026 | G5960S124 | 34 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
MEREO BIOPHARMA GROUP PLC | ADS | 589492107 | 2,061 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 1,154 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
MODERNA INC | COM | 60770K107 | 2,937 | 12,500 | SH | Call | SOLE | 12,500 | 0 | 0 | |
MORPHIC HLDG INC | COM | 61775R105 | 14,129 | 246,201 | SH | SOLE | 246,201 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | COM | 63009R109 | 972 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 9,090 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 3,545 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 6,288 | 140,100 | SH | SOLE | 140,100 | 0 | 0 | ||
PULMONX CORP | COM | 745848101 | 2,647 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
QUANTUM SI INC | COM CL A | 74765K105 | 920 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
RETROPHIN INC | NOTE 2.500% 9/1 | 761299AB2 | 5,993 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 5,315 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
SCHRODINGER INC | COM | 80810D103 | 1,890 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
SPDR SER TR | S&P BIOTECH | 78464A870 | 27,080 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | |
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 2,060 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
THE BEAUTY HEALTH COMPANY | *W EXP 05/04/2026 | 88331L116 | 288 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 1,126 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
VINCERX PHARMA INC | COM NEW | 92731L106 | 10,890 | 838,311 | SH | SOLE | 838,311 | 0 | 0 | ||
ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 7,577 | 142,418 | SH | SOLE | 142,418 | 0 | 0 | ||
ZYMEWORKS INC | COM | 98985W102 | 1,041 | 30,000 | SH | SOLE | 30,000 | 0 | 0 |